Skip to content

Welcome to Discover Pharma! Today is : November 10, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical & Regulatory

  • Advanced Therapies,Clinical & Regulatory,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    Saphnelo self-administration Phase 3 trial meets primary endpoint in systemic lupus erythematosus

    AstraZeneca has reported positive interim results from the Phase 3 [...]

    May 5, 2026
  • Clinical & Regulatory,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics

    Amber Implants secures FDA clearance for VCFix spinal system

    Amber Implants has received FDA 510(k) clearance for its VCFix [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    EADV 2025: Almirall showcases real-world evidence and pipeline progress in dermatology

    Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Servier receives UK marketing authorisation for vorasidenib for low grade glioma

    Servier has received marketing authorisation from the Medicines and Healthcare [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    TransCelerate and Tufts study finds nearly one-third of clinical trial data adds limited value

    A new collaborative study from TransCelerate BioPharma and the Tufts [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Lithuania’s vice minister Daniel Naumovas on health innovation: “We want patients to feel they can get the best treatment here”

    Daniel Naumovas is a scientist, a teacher and, at 31, [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    CellProthera publishes Phase 1/2b data on ProtheraCytes in heart failure patients

    CellProthera has published the first peer-reviewed results from its Excellent [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Aphaia Pharma begins second Phase 2 obesity trial

    Aphaia Pharma has dosed the first patient in a second [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events,Pharmaceuticals and therapeutics

    Almirall study shows psoriasis treatment improves skin and psychological well-being

    Almirall has presented new two-year results from its POSITIVE study [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    BIG D-FOOT trial results on STIMULAN to be presented at EBJIS 2025

    Biocomposites will present new clinical data from the BIG D-FOOT [...]

    May 5, 2026
Previous545556Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ABLi reports biomarker changes supporting disease-modifying potential of Parkinson’s drug
    Categories: Central Nervous System, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Norstella launches agentic AI platform for biopharma decision-making
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development
  • AI model cuts radiopharmaceutical dose mapping to seconds in prostate cancer study
    Categories: Digital & Data, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top